Sono-Tek Corp (SOTK) Q2 2026 Filing Summary
Business Context and Reporting Period
Sono-Tek Corp, a global leader in ultrasonic coating systems for microelectronics, medical, and alternative energy markets, reported results for the quarter and six months ended August 31, 2025 (Fiscal Q2 and H1 2026). The company operates as a non-accelerated filer and smaller reporting company. Its strategy focuses on transitioning from component sales to high-value complete machine solutions.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | H1 2026 (6 Months) | Q2 2025 (3 Months) | H1 2025 (6 Months) |
|---|---|---|---|---|
| Net Sales | $5.16M | $10.30M | $5.16M | $10.19M |
| Gross Profit | $2.59M | $5.25M | $2.52M | $4.97M |
| Gross Margin | 50.2% | 51.0% | 48.7% | 48.8% |
| Operating Income | $0.42M | $0.90M | $0.29M | $0.52M |
| Net Income | $0.42M | $0.91M | $0.34M | $0.67M |
| Diluted EPS | $0.03 | $0.06 | $0.02 | $0.04 |
| Cash & Equivalents | $3.83M | $3.83M | $5.20M (Feb 2025) | $5.20M (Feb 2025) |
| Marketable Securities | $6.74M | $6.74M | $6.73M (Feb 2025) | $6.73M (Feb 2025) |
| Total Liquidity | $10.57M | $10.57M | $11.93M (Feb 2025) | $11.93M (Feb 2025) |
| Debt | $0 | $0 | $0 | $0 |
| Order Backlog | $11.21M | $11.21M | $11.44M (Aug 2024) | $11.44M (Aug 2024) |
Material Changes vs. Prior Period
- Profitability Expansion: Operating income increased 47% in Q2 and 73% in H1 compared to the prior year, driven by improved gross margins and reduced operating expenses.
- Revenue Stability: Net sales remained flat year-over-year in Q2 (+0%) and grew slightly in H1 (+1%), despite a customer-requested shipment delay impacting In-Line Coating Systems in the quarter.
- Product Mix Shift: Medical sales surged 150% in Q2 and 44% in H1, while Industrial sales declined 68% in Q2 due to the non-repetition of a large float glass order from the prior year.
- Geographic Trends: International sales grew significantly, with Asia Pacific sales up 153% in Q2. Foreign sales accounted for 47% of Q2 revenue compared to 32% in the prior year.
- Cash Flow: Operating cash flow turned negative ($1.1M used in H1) compared to a small outflow in the prior year, primarily due to a $1.86M increase in accounts receivable from revised payment terms on a large order.
Guidance, Outlook, and Risks
- Tax Law Impact: The "One Big Beautiful Bill Act" (OBBBA) signed July 4, 2025, restored 100% bonus depreciation and reinstated immediate expensing of R&D costs. This reduced current tax payable and decreased deferred tax assets by approximately $202,000 in H1.
- Outlook: Management expects wide variations in order flow and shipments quarter-to-quarter. The company is transitioning to higher Average Selling Price (ASP) systems, with some exceeding $1 million.
- Risks: Significant customer concentration exists; one customer accounted for 43% of H1 sales and 59% of accounts receivable. The company also faces risks related to supply chain pressures, tariffs, and the timing of large order completions.
- Capital Allocation: The company continues a stock repurchase program, buying 20,640 shares in Q2 for approximately $71,000. No debt is currently outstanding.
Investor Verification Checklist
- Accounts Receivable Quality: Verify the collectability of the $4.4M receivable from the single customer with revised payment terms, which represents 59% of total AR.
- Backlog Conversion: Monitor the conversion rate of the $11.21M backlog into revenue, noting the sequential 50% increase in backlog from Q1.
- Customer Concentration: Assess the risk exposure to the top customer representing 43% of H1 sales and the impact of their production plan shifts.
- Industrial Market Recovery: Track the rebound in the industrial sector, which saw a 67% decline in H1 sales due to the absence of a specific large order.
- Cash Burn vs. Income: Reconcile the strong net income ($0.91M) with the negative operating cash flow ($1.1M) to ensure working capital management remains sustainable.